Related Experiment Video
Updated: Jun 27, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
Long-standing mild hypertransaminasaemia caused by congenital disorder of glycosylation (CDG) type IIx
P L Calvo1, S Pagliardini, M Baldi
1Department of Pediatric Gastroenterology, University of Turin, Regina Margherita Hospital, Piazza Polonia 94, 10126, Turin, Italy. pierluigi.calvo@fastwebnet.i
Abstract:
A 32 year-old asymptomatic male came to our attention with a 21-year history, documented elsewhere, of puzzling increases in his serum transaminase level. At first, very low serum ceruloplasmin level suggested Wilson disease. Two liver biopsies showed mild portal inflammation, steatosis and mild fibrosis. Further investigation revealed low levels of the glycoproteins AT III and clotting factor XI, leading to a diagnosis of congenital disorder of glycosylation (CDG) type II. Further studies as to the cause of this 'apparently new' CDG, are ongoing. On the basis of our data and a literature review, we suggest that subjects with asymptomatic hypertransaminasaemia be screened for CDG.
Related Concept Videos
Inborn Errors of Metabolism
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Lysosomal Hydrolases
Hepatic Encephalopathy
Jaundice
Chronic Pancreatitis II: Pathophysiology
